Special Purpose Vehicles (SPV)

Global Health Impact Network’s angel investment funds typically invest in around ten early stage companies. Using SPVs, we also offer groups of qualified investors opportunities to invest in individual companies that we may or may not also support with fund investments.

Learn more about Investing
Sensifree has developed a continuous, noninvasive hemodynamic monitoring solution.
Elucid provides physicians with a cost-effective means to optimize treatment decisions for patients with known or suspected cardiovascular disease.
Access Vascular produces groundbreaking biomaterial that is fundamentally different than the polyurethane used in conventional vascular catheters.